Virtual Medicinal Product (VMP) - Generic Ryeqo 40mg/1mg/0.5mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Generic Ryeqo 40mg/1mg/0.5mg tablets | Start Date 17-09-2021 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- H01CC54
- BNF Codes
-
- BNF code 06070200
| Code | Start Date | End Date |
|---|---|---|
| 40110411000001106 | 17-09-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Estradiol hemihydrate | Based on Base Substance | Estradiol | 1 mg | |
| Norethisterone acetate | Based on Ingredient Substance | 500 microgram | ||
| Relugolix | Based on Ingredient Substance | 40 mg |
Name
Norethisterone acetate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
500
Strength and UOM (Dmr)
Name
Estradiol hemihydrate
Basis of strength description
Based on Base Substance
BOSS
Estradiol
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
Name
Relugolix
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
40
Strength and UOM (Dmr)
Parent Products
-
VTMRelugolix + Estradiol + Norethisterone acetate
-
VMP(Current) Generic Ryeqo 40mg/1mg/0.5mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet | ||
| 84 tablet |